Systems and methods for treating supraventricular arrhythmias

• US 8,233,982 B2
• Filed: 02/21/2007
• Issued: 07/31/2012
• Est. Priority Date: 02/21/2007
• Status: Active Grant

• Current Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Original Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Inventors: Libbus, Imad
• Primary Examiner(s): BOCKELMAN, MARK
• Application Number:
  US11/677,116
• Publication Number:
  US 20080200960A1
• Time in Patent Office: 1,987 Days
• Field of Search: 607/118, 607/6, 607/7, 607/14, 600515-518
• US Class Current: 607/14
• CPC Class Codes: A61N 1/36114 Cardiac control, e.g. by vagal stimulation stimulating the heart A61N1/362
• CPC Class Codes: A61N 1/3621 for treating or preventing abnormally high heart rate
• CPC Class Codes: A61N 1/3962 in combination with another heart therapy
• CPC Class Codes: A61N 1/39622 Pacing therapy

Abstract

In various method embodiments, a supraventricular arrhythmia event is detected, and a supraventricular arrhythmia treatment, including neural stimulation to elicit a sympathetic response, is delivered in response to a detected supraventricular arrhythmia event. Some embodiments detect a precursor for a supraventricular arrhythmia episode, and deliver prophylactic neural stimulation to avoid the supraventricular arrhythmia event. Some embodiments detect a supraventricular arrhythmia episode, and deliver therapeutic neural stimulation for the supraventricular arrhythmia event.

Claims

1. A device, comprising:

a controller;

an event detection sensor adapted to cooperate with the controller to detect a supraventricular arrhythmia event;

a neural stimulator adapted to stimulate a neural target to elicit a sympathetic response through sympathetic stimulation or parasympathetic inhibition, the controller being adapted to control the neural stimulator to stimulate the neural target in response to the detected supraventricular arrhythmia event for treating the detected supraventricular arrhythmia event; and

a feedback sensor, distinct from the event detection sensor, adapted to sense a physiological response to stimulation of the neural target, the controller being adapted to make a comparison of the sensed physiological response to a target range for the response, and to use the comparison to adjust a stimulation intensity of the stimulation for treating the detected supraventricular arrhythmia event, wherein the feedback sensor is selected from the group consisting of a respiration sensor, a blood pressure sensor, and a nerve traffic sensor.

2. The device of claim 1, wherein the event detection sensor includes a sensor adapted to sense an electrogram reflective of atrial activity.

3. The device of claim 1, wherein the event detection sensor includes a sensor adapted to sense an electrogram reflective of cardiac activity, and further includes a processor adapted to perform a discrimination algorithm to detect the supraventricular arrhythmia event.

4. The device of claim 1, wherein the supraventricular arrhythmia event includes a precursor to a supraventricular arrhythmia episode.

5. The device of claim 1, wherein the supraventricular arrhythmia event includes a supraventricular arrhythmia episode.

6. The device of claim 1, wherein the neural stimulator includes a lead adapted to be intravascularly placed proximate to the neural target to transvascularly stimulate the neural target.

7. The device of claim 6, wherein the neural stimulator includes a lead adapted to be intravascularly placed within a subclavian vein, an innominate vein or an internal jugular vein.

8. The device of claim 1, wherein the neural stimulator includes a lead adapted to be subcutaneously fed to the neural target to deliver the neural stimulation to the neural target through a nerve cuff.

9. The device of claim 1, wherein the neural stimulator is adapted to stimulate sympathetic neural activity in the neural target to elicit a sympathetic response.

10. The device of claim 1, wherein the neural stimulator is adapted to inhibit parasympathetic neural activity in the neural target to elicit a sympathetic response.

11. The device of claim 1, wherein the neural target includes a stellate ganglion.

12. The device of claim 1, wherein the neural target includes a cardiac sympathetic nerve.

13. The device of claim 1, wherein the neural target includes a vagus nerve.

14. The device of claim 1, further comprising a pulse generator adapted to cooperate with the controller to deliver antitachycardia pacing, an antitachycardia shock, or an antiarrhythmia drug.

15. The device of claim 1, wherein the feedback sensor includes the respiration sensor and the respiration sensor is adapted to sense a respiratory response to stimulation of the neural target and the controller is configured to use the respiratory response to control the intensity of the neural stimulation for treating the detected supraventricular event.

16. The device of claim 15, wherein the neural target is a cardiac sympathetic nerve, and the feedback sensor is configured to sense nerve traffic in a vagus nerve.

17. The device of claim 16, further comprising a bifurcated lead configured to access both the cardiac sympathetic nerve and the vagus nerve.

18. The device of claim 1, wherein the controller is configured to receive at least one enable signal to enable the stimulation of the neural target in response to the detected supraventricular arrhythmia event.

19. The device of claim 18, further comprising a clock to provide a clock signal, wherein the enable signal includes the clock signal.

20. The device of claim 18, where the controller is configured to control the neural stimulator to stimulate the neural target, in response to the detected supraventricular event and if enabled by the enable signal, for a stimulation duration of seconds to minutes.

21. The device of claim 18, further comprising an activity sensor to provide an activity signal, wherein the enable signal includes the activity signal.

22. The device of claim 1, further comprising an implantable can with a plurality of electrodes configured for use to detect heart rate.

23. The device of claim 1, wherein the feedback sensor includes the blood pressure sensor and the blood pressure sensor is adapted to sense a blood pressure response to stimulation of the neural target and the controller is configured to use the blood pressure response to control the intensity of the neural stimulation for treating the detected supraventricular event.

24. The device of claim 1, wherein the feedback sensor includes the nerve traffic sensor and the nerve traffic sensor is adapted to sense a nerve traffic response to stimulation of the neural target and the controller is configured to use the nerve traffic response to control the intensity of the neural stimulation for treating the detected supraventricular event.

25. A system, comprising:

means for detecting a supraventricular arrhythmia event;

means for delivering a supraventricular arrhythmia treatment in response to a detected supraventricular arrhythmia event, wherein the means for delivering the supraventricular arrhythmia treatment includes means for delivering neural stimulation to elicit a sympathetic response through sympathetic stimulation or parasympathetic inhibition in response to the detected supraventricular arrhythmia event; and

means for sensing a physiologic response to the neural stimulation, making a comparison of the physiologic response to a target, and using the comparison to adjust an intensity of the neural stimulation delivered in response to the detected supraventricular event, wherein the sensed physiologic response to the neural stimulation is selected from a group of responses consisting of a respiratory response to the neural stimulation, a blood pressure response to the neural stimulation or a nerve traffic response to the neural stimulation.

26. The system of claim 25, wherein the means for delivering neural stimulation to elicit a sympathetic response includes means for stimulating neural activity in a stellate ganglion, means for stimulating neural activity in a cardiac sympathetic nerve, or means for inhibiting neural activity in a vagus nerve.

27. The system of claim 25, wherein the means for delivering a treatment in response to a detected supraventricular arrhythmia event further includes delivering at least one of antitachycardia pacing, an antitachycardia shock, or a drug therapy.